Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels

  1. Prat, A.
  2. Parera, M.
  3. Adamo, B.
  4. Peralta, S.
  5. Perez-Benavente, M.A.
  6. Garcia, A.
  7. Gil-Moreno, A.
  8. Martinez-Palones, J.M.
  9. Baselga, J.
  10. del Campo, J.M.
Zeitschrift:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Datum der Publikation: 2009

Ausgabe: 20

Nummer: 2

Seiten: 294-297

Art: Artikel

DOI: 10.1093/ANNONC/MDN601 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus